Clinical Trial Update: Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating autologous CAR-T cells targeting B7-H3 (iC9-CAR.B7-H3 T Cells) for ovarian cancer, currently recruiting at UNC Lineberger Comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer
• Ovarian Neoplasms

Drugs mentioned

• iC9-CAR.B7-H3 T Cells

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Ovary Neoplasm, Ovarian Cancer | Phase 1 | Status: RECRUITING